Dec 13, 2023
MAPS Celebrates Submission of New Drug Application to FDA for MDMA-Assisted Therapy for PTSD
MAPS incubated the program that generated the first NDA submission for any psychedelic-assisted therapy
Nov 19, 2023
Recap Video from the 2nd Annual Gathering of the Pearl - August 24, 2023
Highlights from the 2nd Annual Gathering of the Pearl on August 24, 2023 at Highland Brewing in Asheville, NC.
Apr 5, 2023
STATEMENT: MAPS-Funded Phase 3 Research Reports Results from Long-Term Observational Follow-Up Study on MDMA-Assisted Therapy for PTSD
Interim results show improvements in PTSD symptom severity lasted at least six months after the last treatment session.